• search
In vitro ADME In vitro ADME

In vitro ADME

In vitro ADME assays catering to every stage of drug discovery; standalone studies and customized assays.

We have more than 16 years of experience in ADME drug discovey services. We have validated ADME assays in place, amenable to customized study design as per customer requirement. Our expert team of scientists cater to the ADME requirements with unparalleled troubleshooting abilities. We have experience in handling small molecules, therapeutic peptides and complex molecules.

Speak to our experts

Physiochemical properties

Solubility & Chemical Stability at different pH, SIF and SGF

Solubility: Kinetic, Thermodynamic, HT Log D

Permeability

Caco-2 Bi-directional permeability, Efflux ratio MDCK, MDCK-LE, MDCK-MDR1, MDCK-BCRP permeability PAMPA

Distribution

Plasma Protein, in vitro Tissue binding

Blood to Plasma Partition

Brain to plasma partition

Metabolism

Microsomal Clearance, S9, Phase I/Phase II, Hepatocyte Clearance

Plasma/ Whole Blood Stability CYP Phenotyping

Drug-Drug Interactions

CYP Inhibition, CYP TDI, kobs

CYP Induction

P-gp and BCRP Inhibition & Substrate Identification

Why Aurigene Pharmaceutical Services?

Quick turnaround time: In vitro Assays: 5 working days

High throughput (96-well plate) assays

Unidirectional and bidirectional permeability

Highly-experienced and expert team of scientists

Virtual Tour

 

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

Country

section

CAPTCHA
この質問はあなたが人間の訪問者であるかどうかをテストし、自動化されたスパム送信を防ぐためのものです。

rightCaptcha

寡核苷酸作为一种新型治疗方式

JULY 02, 2021

寡核苷酸作为一种新型治疗方式

寡核苷酸作为一种治疗类别是发现用于治疗人类疾病的新的重要治疗剂的革命性方法。基于 RNA 的干预有时适用于其他方式不起作用的情况。例如,它可能有助于治疗先天性新陈代谢错误、遗传疾病和罕见病 寡核苷酸疗法是将化学修饰的寡核苷酸用于治疗目的。寡核苷�...

Read More

Methoxy Polyethylene Glycol (m-PEGs)

Aurigene Pharmaceutical Services is a leader in the synthesis of activated MethoxyPolyethyleneGlycol(m-PEGs), With a comprehensive product range and customized services. ...

Read More

Base mediated spirocyclization of quinazoline: one-step synthesis of spiro-isoindolinone dihydroquinazolinones

2020

A novel approach for the spiro-isoindolinone dihydroquinazolinones has been demonstrated from 2- aminobenzamide and 2-cyanomethyl benzoate in the presence of KHMDS as a base to get moderate yields. The reaction has been screened in various bases followed by solvents and a gram scale reaction has also been executed under the given conditions. Based on the controll...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack